Orbis and Heidelberg Engineering announce new partnership at ESCRS congress

News
Article

The non-profit will partner with the imaging company to prevent blindness and fund new retinoblastoma research.

The imaging company will also provide funding to retinoblastoma research.

The imaging company will also provide funding to retinoblastoma research.

On Friday, Orbis, a global charity dedicated to fighting avoidable blindness, announced a partnership programme with Heidelberg Engineering. The announcement was made during the 41st ESCRS annual meeting. In a press release, Orbis announced the collaboration will make use of its e-learning and telemedicine platform Cybersight to train eyecare professionals.

The global mission of Orbis seeks to serve the majority of people with vision loss and blindness; according to the non-profit, 90% of the 1.1 billion people affected live in low- or middle-income countries. Heidelberg Engineering will support live webinars via the Heidelberg Engineering Academy, with new sessions on optical coherence tomography (OCT) and related imaging technologies.

The company will also fund new research on retinoblastoma. This rare retinal cancer most commonly affects 9,000 paeditatric patients worldwide each year, most of whom are under 5 years of age. In a statement, Orbis said 92% percent of children diagnosed live in low- and middle-income countries. Barriers such as late diagnosis, limited accessibility to eye care, and lack of resources contribute to a 40% survival rate within 3 years of diagnosis.

Dr Hunter Cherwek, Vice President, Clinical Services & Technologies at Orbis International, said, “Orbis is delighted to be partnering with Heidelberg Engineering. Retinoblastoma outcomes for children in low-and-middle income countries could be significantly improved with earlier diagnosis and enhanced treatment.”

“As a global leader in imaging and health care technology, Heidelberg Engineering’s generous contribution and partnership will mean we can both offer enhanced knowledge for eye care practitioners via Cybersight, and pioneer new research that will help improve outcomes for children facing retinoblastoma across the world,” Dr Cherwek added.

Reference

1. Leading eye care charity Orbis announces a new partnership with Heidelberg Engineering. News release. Orbis UK. Published 8 September, 2023.

Recent Videos
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
© 2024 MJH Life Sciences

All rights reserved.